November 26, 2018
Mike Grey is the CEO of Mirum Pharmaceuticals, which formed around revitalizing the liver drug maralixibat. Photo courtesy of Lumena
Stories this photo appears in:
In 2014, pharmaceutical Shire bought San Diego company Lumena and its lead drug candidate, called maralixibat. Now maralixibat is back in the hands of former Lumena talent.